NCT04730362

Brief Summary

This study compare the effects of Oral airway vs LMA in preventing anesthesia-induced partial airway obstruction, in an attempt to lessen MRI motion artifacts, which would result in improvements in image quality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 29, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

February 1, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

May 3, 2022

Status Verified

April 1, 2022

Enrollment Period

1.1 years

First QC Date

January 26, 2021

Last Update Submit

April 29, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Image quality of each MRI sequence

    Image quality of each MRI sequence is evaluated by using a scoring system with the following scores: score of 1 (non-diagnostic), score of 2 (poor quality but some diagnostic value), score of 3 (average), score of 4 (good), and score of 5 (excellent).

    During general anesthesia of MRI investigation procedure

Study Arms (2)

Control group

ACTIVE COMPARATOR

20 patients in which a Guedel oral airway will be inserted for airway management and to conduct inhalational anesthetic through face mask fixed with harness to the head and then connected to anesthesia breathing circuit of MRI compatible anesthesia machine for maintenance of anesthesia of O2 and sevoflurane 2-4% .

Device: guedel airwayDrug: propofol bolus and then anesthesia sevoflurane

supraglottic group

ACTIVE COMPARATOR

20 patients in which supraglottic airway laryngeal mask airway (LMA) will be used and then connected to anesthesia breathing circuit of MRI compatible anesthesia machine for maintenance of anesthesia of O2 and sevoflurane 2-4% .

Device: supraglottic airwayDrug: propofol bolus and then anesthesia sevoflurane

Interventions

Anesthesia will be conducted by induction with 1-2 • Mg/kg of an IV propofol bolus and then anesthesia is maintained with an inhalational anesthesia with sevoflurane 2%-4%. The goal is to maintain the patient spontaneous ventilation throughout the procedure. Monitoring of the patients is done by MRI compatible pulse oximetry for heart rate and oxygen saturation which is connected to MRI control room.

Control group

supraglottic airway

supraglottic group

Mg/kg of an IV propofol bolus and then anesthesia is maintained with an inhalational anesthesia with sevoflurane 2%-4%

Control groupsupraglottic group

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • ASA І and II patients
  • Age under 18 years .
  • The patient will need GA and patient Scheduled for MRI brain.

You may not qualify if:

  • Glasgow coma scale ≤ 8
  • Emergency patient with full stomach.
  • Distorted upper airway anatomy making intubation with GA mandatory.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nataional Cancer Instituite

Cairo, Egypt

Location

MeSH Terms

Conditions

Airway Obstruction

Condition Hierarchy (Ancestors)

Respiratory InsufficiencyRespiration DisordersRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Randomization is done using computer generated sequence. Concealment will be achieved by opaque envelope
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Control group : a Guedel oral airway will be inserted for airway management versus supraglottic group patients in which supraglottic airway laryngeal mask airway (LMA) will be used
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Mohammed Abdelfattah Abdelwadod

Study Record Dates

First Submitted

January 26, 2021

First Posted

January 29, 2021

Study Start

February 1, 2021

Primary Completion

March 1, 2022

Study Completion

March 1, 2022

Last Updated

May 3, 2022

Record last verified: 2022-04

Locations